Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase NA 8Phase 1/2 4Phase EARLY_PHASE1 3Phase 2/3 3Phase 1 3Phase 4 1

Status

Unknown 3Recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3Thoracic 1Gastrointestinal 1CNS 1

Conditions

Multiple Myeloma 26Breast Neoplasms 21Colorectal Neoplasms 17Neoplasms 15Lymphoma, B-Cell 15Prostatic Neoplasms 14Stomach Neoplasms 12Carcinoma, Hepatocellular 12Recurrence 11Lung Neoplasms 11Burkitt Lymphoma 11Solid Tumor 10Pancreatic Neoplasms 10Leukemia, Myeloid, Acute 10Carcinoma, Non-Small-Cell Lung 10Uterine Cervical Neoplasms 9Lymphoma, Non-Hodgkin 9Glioblastoma 9Leukemia 8Ovarian Neoplasms 7Sarcoma 6Polycystic Ovary Syndrome 6Glioma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma 5Hematologic Neoplasms 5Head and Neck Neoplasms 5Neuroendocrine Tumors 4Lymphoma, T-Cell, Peripheral 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Unknown × Osteosarcoma × Clear all
NCT06117878 2023-11-07

Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma

Base Therapeutics (Shanghai) Co., Ltd.

Phase EARLY_PHASE1 Unknown
12 enrolled
Sarcoma

Sarcoma, Osteosarcoma

NCT05851456 2023-05-09

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors

Shanghai Yunying Medical Technology

Phase EARLY_PHASE1 Unknown
20 enrolled
Sarcoma

Bone Neoplasms, Sarcoma, Osteosarcoma

NCT04864821 2021-05-06

Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Phase EARLY_PHASE1 Unknown
24 enrolled
CNSGastrointestinalSarcomaThoracic

Lung Neoplasms, Neuroblastoma, Osteosarcoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡